摘要
目的 设计并构建靶向Tsc1和Tsc2基因的CRISPR/Cas9基因编辑系统,并在细胞水平验证基因编辑效力。方法针对小鼠Tsc1和Tsc2基因分别设计3个sgRNA导向序列,构建sgRNA表达载体,与Cas9表达质粒共转染小鼠N2a细胞,经药物筛选获得阳性细胞后,PCR扩增打靶位点的DNA片段,利用TA克隆测序验证打靶效率。结果 Tsc1基因Tsc1-M-sgRNA2、Tsc1-M-sgRNA3及Tsc2基因Tsc2-M-sgRNA1、Tsc2-M-sgRNA2、Tsc2-M-sgRNA3这5个靶点均发生基因编辑,编辑效率分别为40%、80%、30%、30%和20%。结论 成功构建了有编辑效力的靶向小鼠Tsc1和Tsc2基因的CRISPR-Cas9基因编辑系统。
Objective To design and construct CRISPR/Cas9 gene editing system targeting Tsc1 and Tsc2 genes,and verify the effectiveness of gene editing at cellular level.MethodsThree sgRNA guide sequences were designed for mouse Tsc1 and Tsc2 genes respectively.The sgRNA expression vector was constructed and co-transfected with the Cas9 expression plasmid into mouse N2a cells.After the positive cells were obtained through drug screening,the DNA fragments at the targeting site were amplified by PCR,and the targeting efficiency was verified by TA clone sequencing.ResultsThe five targets of Tsc1-M-sgRNA2 and Tsc1-M-sgRNA3 of Tsc1 gene and Tsc2-M-sgRNA1,Tsc2-M-sgRNA2 and Tsc2-M-sgRNA3 of Tsc2 gene were all edited,and the editing efficiency was 40%,80%,30%,30% and 20%,respectively.ConclusionA CRISPR-Cas9 gene editing system with editing efficiency targeting mouse Tsc1 and Tsc2 genes was successfully constructed.
作者
杨玲玲
陈玲
李锦昆
王川贵
李勇
岳鹏鹏
于鸿浩
YANG Lingling;CHEN Ling;LI Jinkun;WANG Chuangui;LI Yong;YUE Pengpeng;YU Honghao(School of Intelligent Medicine and Biotechnology,Key Laboratory of Medical Biotechnology and Translational Medicine,Guilin Medical University,Education Department of Guangxi Zhuang Autonomous Region,Guilin 541199,Guangxi Zhuang Autonomous Region,China)
出处
《中国生物制品学杂志》
CAS
CSCD
北大核心
2023年第4期400-405,共6页
Chinese Journal of Biologicals
基金
国家自然科学基金(31860302,32160147)
广西自然科学基金(2018JJA140455)
广西科技基地和人才专项(2019-AC20329)。